Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MITF | O75030 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MLYCD | O95822 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | HPGD | P15428 | 2/20 | 0.30 |
| ▸ | TSHR | P16473 | 2/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3566249 | 0.93 | LMNA (0.37) | SMN1; SMN2KMT2ALMNAALDH1A1TSHR | |
| SCHEMBL4961794 | 0.81 | SMN1; SMN2 (0.38) | MITFSMN1; SMN2KMT2ALMNAALDH1A1 | |
| SCHEMBL27648209 | 0.80 | MITF (0.39) | MITFSMN1; SMN2KMT2ALMNAALDH1A1 | |
| SCHEMBL27670204 | 0.79 | INMT (0.32) | MLYCD | |
| SCHEMBL28812249 | 0.78 | MITF (0.40) | MITFSMN1; SMN2KMT2ALMNAALDH1A1 | |
| SCHEMBL16112033 | 0.78 | SMN1; SMN2 (0.40) | MITFSMN1; SMN2KMT2ALMNAALDH1A1 | |
| SCHEMBL8104688 | 0.76 | LMNA (0.40) | MITFSMN1; SMN2KMT2ALMNAALDH1A1 | |
| SCHEMBL28310972 | 0.76 | LMNA (0.31) | LMNA | |
| SCHEMBL14693810 | 0.76 | TSHR (0.40) | MITFSMN1; SMN2KMT2ALMNAALDH1A1 | |
| SCHEMBL11100555 | 0.76 | KMT2A (0.36) | MITFSMN1; SMN2KMT2ALMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107556241-A | The method and apparatus that caprolactam is prepared by trifluoroacetic acid catalysis of pimelinketone oxime Beckmann rearrangement | 沧州旭阳化工有限公司 | 2018-01-09 | — | — | CN | disclosed |
| CN-103288734-B | Catalyst system for Beckmann rearrangement and method for preparing caprolactam thereof | BEIJING ENERGY ENG TECHNOLOGIES CO LTD | 2015-04-29 | — | — | CN | disclosed |
| US-7220869-B2 | Brønsted acidic room temperature ionic liquids each having a N-protonated lactam cation and method for preparing the same | LANZHOU INSTITUTE OF CHEMICAL PHYSICS CHINESE ACADEMY OF SCIENCES (CN) | 2007-05-22 | — | — | US | disclosed |
| US-20070021604-A1 | Bronsted acidic room temperature ionic liquids each having a N-protonated lactam cation and method for preparing the same | LANZHOU INSTITUTE OF CHEMICAL PHYSICS CHINESE ACADEMY OF SCIENCES | 2007-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070021604-A1 | Bronsted acidic room temperature ionic liquids each having a N-protonated lactam cation and method for preparing the same | SLC7A5, ALAD, SLC7A1 | MITF 3945/4885SMN1; SMN2 1396/4885KMT2A 4486/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.